Download PDF
Thromb Haemost 1975; 33(01): 073-076
DOI: 10.1055/s-0038-1647813
Meeting of the International Committee on Thrombosis and Haemostasis — Symposium on Heparin, Basel, Switzerland, September, 1974
Schattauer GmbH

Antilipemic Action of Heparin[*]

F Markwardt
1   Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, G. D. R.
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.


 

  • References

  • 1 Anfinsen Ch. B, Boyle E, Brown R. K. The role of heparin in lipoprotein metabolism. Science 1952; 115: 583.
    CrossrefPubMedGoogle Scholar
  • 2 Ballard K, Fredholm B. B, Meng H. C, Rosell S. Heparin-induced release of lipase activity from perfused canine subcutaneous adipose tissue. Experimental Biology and Medicine 1971; 137: 1490.
    CrossrefPubMedGoogle Scholar
  • 3 Bierman E. L, Porte Jr. D, Bagdade J. D, Hazzard W. R. Lipoprotein lipase and plasma triglyceride. In R. J. Jones (ed.). Atherosclerosis, Proceedings of the Second International Symposium. Springer, Berlin, Heidelberg; New York: 1970: 230.
    Google Scholar
  • 4 Boberg J, Carlson L. A, Normell L. Production of lipolytic activity by the isolated perfused dog liver in response to heparin. Life Sciences 1964; 3: 1011.
    CrossrefPubMedGoogle Scholar
  • 5 Deutsch E. Klinische Anwendung der Anticoagulantien. In F. Maekwaedt (ed.). Handbuch der experimentellen Pharmakologie, Anticoagulantien. Vol. 27 Springer, Berlin, Heidelberg; New York: 1971: 302.
    Google Scholar
  • 6 Fielding C. J. Purification of lipoprotein lipase from rat post-heparin plasma. Biochimica et Biophysica Acta (Amst.) 1969; 178: 499.
    CrossrefPubMedGoogle Scholar
  • 7 Fielding C. J. Further characterization of lipoprotein lipase and hepatic post-heparin lipase from rat plasma. Biochimica et biophysica Acta (Amst.) 1972; 280: 569.
    CrossrefPubMedGoogle Scholar
  • 8 Gastpar H. Physiologische Bedeutung und pharmakologische Wirkungen des Heparins. Thrombosis et Diathesis Haemorrhagica 1965 Suppl. 16..
    PubMedGoogle Scholar
  • 9 Greten H, Levy R. I, Frederickson D. S. Evidence for separate mono- giyceride hydrolase and triglyceride lipase in post-heparin human plasma. Journal of Lipid Research 1969; 10: 326.
    PubMedGoogle Scholar
  • 10 Hahn P. F. Abolishment of alimentary lipemia following injection of heparin. Science 1943; 98: 19.
    CrossrefPubMedGoogle Scholar
  • 11 Jorpes J. E. Heparin. In F. Markwardt (ed.) Handbuch der experimentellen Pharmakologie, Anticoagulantien. Vol. 27. Springer, Berlin, Heidelberg; New York: 1971: 143.
    Google Scholar
  • 12 Korn E. D. Clearing factor, a heparin activated lipoprotein lipase. Journal of Biological Chemistry 1955; 215: 1.
    PubMedGoogle Scholar
  • 13 Korn E. D. Lipoprotein lipase. In: Page I. H. : Chemistry of Lipids as Related to Atherosclerosis. Thomas, Springfield, I11 1958: 169.
    Google Scholar
  • 14 Kraupp O. Der Mechanismus der Klärwirkung des Heparins. Wiener klinische Wochenschrift 1956; 68: 937.
    PubMedGoogle Scholar
  • 15 Kurien V. A, Yates P. A, Oliver M. F. Free fatty acids, heparin, and arrhythmias during experimental myocardial infarction. Lancet 1969; II: 185.
    PubMedGoogle Scholar
  • 16 Nordøy A, Strøm E, Berntsen H. Effect of high plasma FFA induced by heparin during alimentary hyperlipaemia on platelets. Thrombosis Research 4 Suppl. 1 71. 1974;
    CrossrefPubMedGoogle Scholar
  • 17 Payza A. N, Eiber H. B, Walter S. Studies with clearing factor. V. State of tissue lipases after injection of heparin. Proceedings of the Society for Experimental Biology 1967; 125: 188.
    PubMedGoogle Scholar
  • 18 Porte Jr. D, Bierman E. L. The effect of heparin infusion on plasma triglyceride in vivo and in vitro with a method for calculating triglyceride turnover. Journal of Laboratory and Clinical Medicine 1969; 73: 631.
    PubMedGoogle Scholar
  • 19 Robinson D. S. The clearing factor lipase activity of adipose tissue. In: A. E. Renold G. F. Cahill (eds.). Handbook of Physiology, Sect. 5. American Physiological Society; Washington, D. C.: 295. 1965
    Google Scholar
  • 20 Robinson D. S. The role of clearing factor lipase in the removal of chylomicron triglycerides from the blood. In: G. Cowgill L. W. Kinsell (eds.). Proceedings of the 1967 Deuel Conference on Lipids on the Fate of Dietary Lipids U. S. Government Printing Office; Washington, D. C.: 1967: 166.
    Google Scholar
  • 21 Schettler G. Die klinische Bedeutung der Lipoproteidlipase. In: Lipoproteid- lipase, Symposium, Wien 1962. Karger, Basel 1963: 106.
    Google Scholar
  • 22 Vogel W. C, Bierman E. L. Post-heparin serum lecithinase in man and its positional specificity. Journal of Lipid Research 1967; 8: 46.
    PubMedGoogle Scholar
  • 23 Woldow A, Chapman J. E, Evans J. M. Fat tolerance test in subjects with arteriosclerosis. Heparin effects upon lipemia lipoproteins and gamma globulin. American Heart Journal 1954; 47: 568.
    CrossrefPubMedGoogle Scholar
  • 24 Wolf R, Beck O. A, Hochrein H. Der Einfluß von Heparin auf die Häufigkeit von Rhythmusstörungen beim akuten Myokardinfarkt. Deutsche medizinische Wochenschrift 1974; 99: 1549.
    Article in Thieme ConnectPubMedGoogle Scholar